Pfizer closes Ferrosan Consumer Health deal
This article was originally published in Scrip
Pfizer says it has closed its purchase of the consumer healthcare firm, Ferrosan. The US firm announced its intention to buy the Danish company earlier this year (scripintelligence.com, 7 February 2011). Ferrosan's business includes dietary supplements and lifestyle products and should broaden Pfizer's own portfolio. "Ferrosan Consumer Health's innovative products and geographic footprint are a strong fit for our business," said Paul Sturman, president of Pfizer Consumer Healthcare. The financial details of the deal have not been disclosed.